Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003143413 | SCV003828371 | uncertain significance | not provided | 2020-10-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003358154 | SCV004063967 | uncertain significance | Inborn genetic diseases | 2023-06-16 | criteria provided, single submitter | clinical testing | The c.6547A>G (p.T2183A) alteration is located in exon 9 (coding exon 9) of the FREM2 gene. This alteration results from a A to G substitution at nucleotide position 6547, causing the threonine (T) at amino acid position 2183 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |